These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20828300)

  • 1. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations.
    Häussler MD
    Acta Radiol; 2010 Oct; 51(8):924-33. PubMed ID: 20828300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices.
    Zhang BC; Hou L; Lv B; Xu YW
    Br J Radiol; 2014 Feb; 87(1034):20130325. PubMed ID: 24357597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography - The COMFORT II Trial.
    Rosenberg C; Martínez-Rodrigo JJ; Lonjedo Vicent E; Macho J; Lim L; Todoran TM;
    J Invasive Cardiol; 2017 Jan; 29(1):9-15. PubMed ID: 28045670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events with universal use of iodixanol for CT: comparison with iohexol.
    Ho AL; O'Malley ME; Tomlinson GA
    J Comput Assist Tomogr; 2007; 31(2):165-8. PubMed ID: 17414747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open label, prospective, multicenter, non-interventional study of iodixanol 270 mg I/mL for use in individuals undergoing computed tomography angiography in real-world clinical practice.
    Du X; Lu B; Hu D; Song B; Li K
    Acta Radiol; 2019 Feb; 60(2):177-185. PubMed ID: 29886757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discomfort assessment in peripheral angiography: randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia.
    Palena LM; Sacco ZD; Brigato C; Sultato E; Barra D; Candeo A; Manzi M
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):1019-25. PubMed ID: 24478190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed adverse reactions to iodinated contrast media and their risk factors.
    Hosoya T; Yamaguchi K; Akutsu T; Mitsuhashi Y; Kondo S; Sugai Y; Adachi M
    Radiat Med; 2000; 18(1):39-45. PubMed ID: 10852654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodixanol in multidetector-row computed tomography angiography (MDCTA): diagnostic accuracy for abdominal aorta and abdominal aortic major-branch diseases using four-, eight- and 16-detector-row CT scanners.
    Nonent M; Thouveny F; Simons P; Cappeliez O; Reiser MF; Duddalwar V; Bonomo L; Liessi G
    Acta Radiol; 2007 Feb; 48(1):48-58. PubMed ID: 17325925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
    Sohn KH; Kim GW; Lee SY; Kim HS; Cho SH; Han JK; Kang HR
    Eur Radiol; 2019 Oct; 29(10):5314-5321. PubMed ID: 30937592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodixanol in cerebral computed tomography: a randomized, double-blind, phase-III, parallel study with iodixanol and iohexol.
    Doerfler A; Fiebach J; Wanke I; Forsting M; Henseke P; Sartor K
    Eur Radiol; 1999; 9(7):1362-5. PubMed ID: 10460375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Discomfort during Carotid Artery Stenting: A Comparison Study between Iodixanol versus Iopamidol.
    Borrelli MP; Setacci F; de Donato G; Galzerano G; Benevento D; Mele M; Rosadini D; Messina G; Setacci C
    Ann Vasc Surg; 2017 Feb; 39():167-172. PubMed ID: 27521830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database.
    An J; Jung H; Kwon OY; Kang Y; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Allergy Clin Immunol Pract; 2019; 7(7):2205-2211. PubMed ID: 30877072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging.
    Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A
    J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.